-
-
-
-
-
-
-
Amicus Therapeutics (FOLD) Tops Q2 EPS by 12c, provides guidance
-
-
-
-
-
-
-
Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
-
-
-
-
-
-
-
Amicus Therapeutics (FOLD) Tops Q2 EPS by 11c, provides guidance
-
-
-
-
-
-
-
WuXi Biologics Reports Solid 2023 Annual Results
-
-
-
-
-
-
-
WuXi Biologics Reports Solid 2023 Interim Results
-
-
-
-
-
-
-
Amicus Therapeutics Announces Full-Year 2022 Financial Results and Corporate Updates
-
-
-
-
-
-
-
CORRECTING AND REPLACING -- Amicus Therapeutics Announces First Quarter 2022 Financial Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

